Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy.
All abaloparatide-related impurity standards are available from Venkatasai, together with certified COAs and characterization data like IR, mass, HPLC, purity, NMR, and TGA reports. In accordance with the regulations, we also offer CMR, DEPT, and thorough structure characterization reports. Major pharmaceutical companies all around the world employ standards connected to abaloparatide for their ANDA/DMF applications.